# Cambrex Profarmaco Milano Srl – FDA Inspection, May 19, 2017

Source: https://www.keypedia.com/records/fda_inspections/cambrex-profarmaco-milano-srl/66ac1960-e277-4a92-bdb1-667be3edb250
Source feed: FDA_Inspections

> FDA inspection 1021644 of Cambrex Profarmaco Milano Srl, May 19, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1021644
- Company Name: Cambrex Profarmaco Milano Srl
- Inspection Date: 2017-05-19
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1193220 - 2022-11-11](https://www.keypedia.com/records/fda_inspections/cambrex-profarmaco-milano-srl/d517f310-c80c-4a43-a918-722116697891)
- FDA Inspection 1167505 - 2021-10-01
- FDA Inspection 1091698 - 2019-05-07
- FDA Inspection 973972 - 2015-11-06
- FDA Inspection 861141 - 2013-12-06

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/margaret-m-annes/e528fbbe-2a4c-4697-9256-b7f2d0bcd279)
- [Temar Q. Williams](https://www.keypedia.com/people/temar-q-williams/624784fb-dd87-482b-9e8c-a6d79736b132)

Company: https://www.keypedia.com/companies/cambrex-profarmaco-milano-srl/5855fd12-020f-4975-9bc0-f5358c581aef

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c